Hamlet BioPharma AB Logo

Hamlet BioPharma AB

Developing selective therapies for cancer and infections like bladder cancer and UTIs.

HAMLET | SPGR

Overview

Corporate Details

ISIN(s):
SE0015661145 (+2 more)
LEI:
549300HJV2LJY4CDBR64
Country:
Sweden
Address:
Klinikgatan 32, 222 42 LUND
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Hamlet BioPharma AB is a clinical-stage pharmaceutical company developing novel therapies for cancer and infections. Its lead oncology candidate, Alpha1H, is a tumor-killing protein-lipid complex designed to selectively target and eliminate tumor cells while sparing healthy tissue. Alpha1H has successfully completed Phase II trials for bladder cancer, demonstrating significant tumor reduction and immune system activation. The company is also advancing immunotherapy as an alternative to antibiotics. Its IL-1 inhibitor, anakinra, has completed Phase II studies showing positive results in treating patients with recurrent urinary tract infections and Bladder Pain Syndrome (interstitial cystitis). Hamlet BioPharma's pipeline focuses on creating highly specific treatments with improved safety profiles for significant unmet medical needs.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Hamlet BioPharma AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Hamlet BioPharma AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland FARN
Fluicell AB Logo
Developing bioprinted tissues for regenerative medicine and advanced drug screening.
Sweden FLUI
FluoGuide A/S Logo
Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.
Denmark FLUO
FUSION ANTIBODIES PLC Logo
A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.
United Kingdom FAB
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom FUM
GENINCODE PLC Logo
AI-powered genetic tests for physicians, predicting and preventing cardiovascular disease.
United Kingdom GENI
Genomic Vision Logo
Develops DNA analysis tools using Molecular Combing for genetic research and diagnostics.
France GV
Genxone Spolka Akcyjna Logo
A biotech firm offering nanopore DNA/RNA sequencing services and medical diagnostics.
Poland GX1
Hipower Energy Spolka Akcyjna Logo
Develops hydrogen solutions, mobile refueling, and CO2-to-methanol tech for energy markets.
Poland HPE
Israel HRON

Talk to a Data Expert

Have a question? We'll get back to you promptly.